Daily Archives: September 2, 2016

Corporate villains are sometimes behind sudden increases in drug prices, but these unwanted surprises are often the result of a complicated and opaque healthcare system. The FT’s David Crow joins Cardiff Garcia and Mary Childs to discuss in this snack-sized episode of the weekly podcast. Visit FT.com/Alphachat for show notes and links.

 

The market has become more sanguine about the devaluation of the Chinese currency in recent months. Geoffrey Yu of UBS discusses what has changed and tells Rochelle Toplensky what we can expect in the event of a Fed rate rise.

 

With Henry Mance and James Blitz of the Financial Times. Presented by Sebastian Payne.